In this context, EZH2 inhibition activates a double-stranded RNA–STING–ISG stress response upregulating genes involved in antigen presentation, Th1 chemokine signaling, interferon response, the intratumoral trafficking of activated CD8+ T-cells, and increased M1 tumor-associated macrophages [208]. The gene discussed is CD8A; the disease is neoplasm.